The World Health Organisation (WHO) recently noted that “researchers are working at break-neck speed” to understand SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). They are also working to develop potential vaccines, medicines and other technologies that are affordable and equitable. By June 2020 – six months since it was first identified – thousands of therapeutic trials and dozens of vaccine development studies were under way, including one vaccine study each in South Africa and Nigeria.
The government of Rwanda has been a foremost champion of women in ICT and in the fields of science, technology, engineering and mathematics (also known as STEM), by driving initiatives like the establishment of the Carnegie Mellon University-Africa campus, for which the Bank provided funding. Students from 17 different countries pursue highly specialized ICT skills at the Africa campus.
Africa faces a range of public health challenges, from infectious diseases such as cholera, malaria, Ebola, HIV, and more recently, coronavirus, to a growing burden of chronic diseases. Other problems in Africa, including poverty, armed conflicts, and government mismanagement, complicate efforts to address health issues.
The financing, which includes more than $53 billion for Africa, will help countries invest in the needs of their people, boost economic growth, and bolster resilience to climate shocks and natural disasters.
An innovative graphene-based film helps shield people from disease-carrying mosquitos, according to a new study funded by the National
Mini grids have the potential to provide electricity to as many as 500 million people by 2030, with the right policies and about $220 billion of investment to build around 210,000 mini grids.
The prospect of a fully sustainable Blue Economy for Africa gathered significant momentum following the second Africa Blue Economy Forum held in Tunis on 25-26 June.